<>
<>
<>
<>
<>
<>
<>
Pinnacle
The accent of the Company on chronic and lifestyle ailments is aided by this division. Through Pinnacle, the Company provides a judicious mélange of drugs addressing chronic and lifestyle diseases, those are constantly on the rise. It caters to a specialist’s group comprising Cardiologists, and Consulting Physicians. ORG IMS estimates the Cardiac Market in India to be around Rs.34,847 mn with a growth rate of 23.4%. In the CVS segment, Lupin commands a 5.1% market share and is positioned in the top 10 companies for this segment.

Key Products : Pinnacle

Product

Therapeutic Segment

Product Rank In the relevant segment

Clopitab

CVS

1

Tonact

CVS

2

Ramistar

CVS

2

Lupenox

CVS

2

Nebistar

CVS

2




<>
<> <> <>
<>
<>
<>